How Medical Affairs Engages with two Types of Digital Opinion Leaders
This podcast addresses two important categories of Digital Opinion Leaders (DOLs) we should all be listening to.
This author has not written his bio yet.
But we are proud to say that Medical Affairs contributed 333 entries already.
This podcast addresses two important categories of Digital Opinion Leaders (DOLs) we should all be listening to.
MAPS is honored to announce the appointment of William (Bill) Sigmund, MD, MHS, EVP and Chief Medical Officer at Becton Dickinson, to the MAPS Board of Directors.
The real value of AI is reaped when complex data is transformed into clear, easy-to-understand recommendations that are surfaced at the point of execution.
The use and acceptance of real-world evidence (RWE) in the pharmaceutical and biotechnology industries has increased dramatically in the last 5 years. Approximately 70% of new drug and biologic regulatory submissions to the U.S Food and Drug Administration (FDA) now include RWE.1 Nearly 95% of pharmaceutical industry respondents, in a recent survey by Deloitte, expect RWE to play an important role in their companies by 2022.2 Medical Affairs (MA) professionals are in a unique position to champion the use of RWE internally and communicate its value both internally and externally. This white paper focuses on providing MA professionals with the background and history of RWE, and its potential applications in the biopharma industry, so that they may incorporate this knowledge into their areas of functional expertise, and ultimately, benefit patients and consumers in their healthcare decision-making.
MAPS speaks with Lance Hill about the opportunity for Medical Affairs organizations to modernize their operations in the pre-launch and launch phase by harnessing insights management technology.
Insights On Demand is a data-driven and individualized process that allows you to automate putting immediately actionable insight into the hands of those that can take immediate action. Learn the 3 A’s of Automatic Insights.
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
Digitalization offers Medical Affairs teams the opportunity to rethink strategy and actions across the lifecycle of traditional and nontraditional products.
In this podcast, experts demonstrate how to implement AI-powered natural language processing to gather, interpret and integrate insights to uncover the story in your data.
This podcast previews the MAPS 2022 Global Annual Meeting session “How Medical Affairs can best support internal and external collaborations in patient engagement,” that details the unique role of Medical Affairs in patient engagement.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.